Johannessen TC - Search Results

1

Molecular mechanisms of temozolomide resistance in glioblastoma multiforme.

Johannessen TC, Bjerkvig R. Johannessen TC, et al. Expert Rev Anticancer Ther. 2012 May;12(5):635-42. doi: 10.1586/era.12.37. Expert Rev Anticancer Ther. 2012. PMID: 22594898 Review.

2

The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells.

Johannessen TC, Prestegarden L, Grudic A, Hegi ME, Tysnes BB, Bjerkvig R. Johannessen TC, et al. Neuro Oncol. 2013 Mar;15(3):269-78. doi: 10.1093/neuonc/nos301. Epub 2012 Dec 20. Neuro Oncol. 2013. PMID: 23258843 Free PMC article.

3

Tumor vasculature: the Achilles' heel of cancer?

Johannessen TC, Wagner M, Straume O, Bjerkvig R, Eikesdal HP. Johannessen TC, et al. Expert Opin Ther Targets. 2013 Jan;17(1):7-20. doi: 10.1517/14728222.2013.730522. Epub 2012 Nov 2. Expert Opin Ther Targets. 2013. PMID: 23121690 Review.

4

DNA repair and cancer stem-like cells--potential partners in glioma drug resistance?

Johannessen TC, Bjerkvig R, Tysnes BB. Johannessen TC, et al. Cancer Treat Rev. 2008 Oct;34(6):558-67. doi: 10.1016/j.ctrv.2008.03.125. Epub 2008 May 22. Cancer Treat Rev. 2008. PMID: 18501520 Review.

5

Phosphoglycerate mutase 1 (PGAM1) overexpression promotes radio- and chemoresistance in gliomas by activating the DNA damage response.

Johannessen TA, Mukherjee J. Johannessen TA, et al. Mol Cell Oncol. 2021 Mar 22;8(2):1875804. doi: 10.1080/23723556.2021.1875804. eCollection 2021. Mol Cell Oncol. 2021. PMID: 33860077

6

Phosphoglycerate Mutase 1 Activates DNA Damage Repair via Regulation of WIP1 Activity.

Ohba S, Johannessen TA, Chatla K, Yang X, Pieper RO, Mukherjee J. Ohba S, et al. Cell Rep. 2020 Apr 14;31(2):107518. doi: 10.1016/j.celrep.2020.03.082. Cell Rep. 2020. PMID: 32294440 Free article.

7

A new chance for EGFR inhibition in glioblastoma?

Johannessen TA, Bjerkvig R. Johannessen TA, et al. Neuro Oncol. 2019 Dec 17;21(12):1487-1488. doi: 10.1093/neuonc/noz196. Neuro Oncol. 2019. PMID: 31628474 Free PMC article. No abstract available.

8

Thioridazine inhibits autophagy and sensitizes glioblastoma cells to temozolomide.

Johannessen TC, Hasan-Olive MM, Zhu H, Denisova O, Grudic A, Latif MA, Saed H, Varughese JK, Røsland GV, Yang N, Sundstrøm T, Nordal A, Tronstad KJ, Wang J, Lund-Johansen M, Simonsen A, Janji B, Westermarck J, Bjerkvig R, Prestegarden L. Johannessen TC, et al. Int J Cancer. 2019 Apr 1;144(7):1735-1745. doi: 10.1002/ijc.31912. Epub 2018 Dec 11. Int J Cancer. 2019. PMID: 30289977 Free article.

9

Mutant IDH1 Cooperates with ATRX Loss to Drive the Alternative Lengthening of Telomere Phenotype in Glioma.

Mukherjee J, Johannessen TC, Ohba S, Chow TT, Jones L, Pandita A, Pieper RO. Mukherjee J, et al. Among authors: johannessen tc. Cancer Res. 2018 Jun 1;78(11):2966-2977. doi: 10.1158/0008-5472.CAN-17-2269. Epub 2018 Mar 15. Cancer Res. 2018. PMID: 29545335 Free article.

10

Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation Process.

Ohba S, Mukherjee J, Johannessen TC, Mancini A, Chow TT, Wood M, Jones L, Mazor T, Marshall RE, Viswanath P, Walsh KM, Perry A, Bell RJ, Phillips JJ, Costello JF, Ronen SM, Pieper RO. Ohba S, et al. Among authors: johannessen tc. Cancer Res. 2016 Nov 15;76(22):6680-6689. doi: 10.1158/0008-5472.CAN-16-0696. Epub 2016 Oct 6. Cancer Res. 2016. PMID: 27758882 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results